MITA receives Commerce Department funding to increase exports
The Medical Imaging & Technology Alliance (MITA) was awarded money from the Commerce Department’s International Trade Administration Market Development Cooperator program to increase exports and expand access to diagnostic medical imaging, radiation therapy and radiopharmaceuticals in new markets.
Under a three-year agreement with the Department of Commerce dubbed the “Global Diagnostic and Therapeutic Improvement Initiative,” the program will aim to promote harmonization of international standards, reduce unnecessary regulations and improve global competitiveness in medical imaging markets.
“This funding and partnership will enhance MITA members’ ability to bring innovative imaging technologies to market, improve global access to life-saving therapies and diagnostic equipment and create good-paying jobs right here at home,” Dave Fisher, executive director, MITA, said in a statement.
The International Trade Association will provide more than $200,000 in funding as one piece of a three-part program that includes support from MITA and industry. MITA will strive to identify problems and work closely with regulators in China and India to integrate with international standards and market environments.
Under a three-year agreement with the Department of Commerce dubbed the “Global Diagnostic and Therapeutic Improvement Initiative,” the program will aim to promote harmonization of international standards, reduce unnecessary regulations and improve global competitiveness in medical imaging markets.
“This funding and partnership will enhance MITA members’ ability to bring innovative imaging technologies to market, improve global access to life-saving therapies and diagnostic equipment and create good-paying jobs right here at home,” Dave Fisher, executive director, MITA, said in a statement.
The International Trade Association will provide more than $200,000 in funding as one piece of a three-part program that includes support from MITA and industry. MITA will strive to identify problems and work closely with regulators in China and India to integrate with international standards and market environments.